http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101610417-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate | 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101610417-B1 |
| titleOfInvention | 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| abstract | The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use in the treatment of peripheral vascular, visceral vascular, and vascular complications associated with platelet aggregation, including thrombosis in humans and other mammals. Related to their use as P2Y 12 receptor antagonists in the treatment and / or prevention of hepatic vascular, renal vascular, cardiovascular and cerebrovascular diseases or disorders, do. |
| priorityDate | 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.